Rainmed Medical Limited (HKG:2297)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.1660
+0.0020 (1.22%)
May 19, 2025, 1:47 PM HKT
-41.75%
Market Cap 191.52M
Revenue (ttm) 42.38M
Net Income (ttm) -120.78M
Shares Out 1.17B
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 141,000
Average Volume 647,050
Open 0.1650
Previous Close 0.1640
Day's Range 0.1650 - 0.1660
52-Week Range 0.1280 - 0.7000
Beta 1.04
RSI 39.81
Earnings Date May 30, 2025

About Rainmed Medical

Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of coron... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2014
Employees 270
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2297
Full Company Profile

Financial Performance

In 2024, Rainmed Medical's revenue was 39.82 million, a decrease of -45.61% compared to the previous year's 73.22 million. Losses were -113.50 million, -2.02% less than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.